This article is 3 years old
J&J booster shot slashes Omicron hospitalisations - South African study
A booster dose of Johnson & Johnson Inc's single-dose Covid-19 vaccine was 84 percent effective at preventing hospitalisation in South African healthcare workers who became infected as the Omicron variant spread, researchers said on Thursday.
The real-world study, which has not been peer-reviewed, was based on a second dose of the J&J vaccine administered to 69,092 workers between Nov 15 and Dec. 20...
Verifying user
RM12.50 / month
- Unlimited access to award-winning journalism
- Comment and share your opinions on all our articles
- Gift interesting stories to your friends
- Tax deductable